Rebecca Drain served as our Vice President, Regulatory Affairs and Quality most recently and joined the company as Executive Director of Regulatory Affairs and Quality Assurance in July 2019. In August 2022 she became and currently serves as a consultant for the company. Prior to joining Intensity Therapeutics, Ms. Drain had nearly 25 years of experience with Bristol Myers Squibb, where most recently, between January 2015 and December 2018, she served as Director, Submission Management, Global Regulatory Safety and Biometrics, a position in which she was responsible for global oncology regulatory submissions. Prior to BMS, she was a research scientist with a drug discovery company. Ms. Drain earned a B.S. in Pathobiology from the University of Connecticut.